Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginTimes Interest Earned

Cellectis (CLLS) Enterprise Value (2016 - 2025)

Cellectis has reported Enterprise Value over the past 12 years, most recently at -$61.7 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$61.7 million for Q4 2025, up 76.3% from a year ago — trailing twelve months through Dec 2025 was -$61.7 million (up 76.3% YoY), and the annual figure for FY2025 was -$61.7 million, up 76.3%.
  • Enterprise Value for Q4 2025 was -$61.7 million at Cellectis, up from -$260.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for CLLS hit a ceiling of -$1.1 million in Q2 2023 and a floor of -$260.3 million in Q4 2024.
  • Median Enterprise Value over the past 5 years was -$143.6 million (2021), compared with a mean of -$133.7 million.
  • Biggest five-year swings in Enterprise Value: tumbled 89.58% in 2023 and later surged 76.3% in 2025.
  • Cellectis' Enterprise Value stood at -$186.1 million in 2021, then soared by 45.67% to -$101.1 million in 2022, then tumbled by 89.58% to -$191.7 million in 2023, then tumbled by 35.78% to -$260.3 million in 2024, then surged by 76.3% to -$61.7 million in 2025.
  • The last three reported values for Enterprise Value were -$61.7 million (Q4 2025), -$260.3 million (Q4 2024), and -$191.7 million (Q4 2023) per Business Quant data.